Androgen deprivation therapy (ADT) can slow the growth of aggressive prostate cancer and prolong survival in men with metastatic castration-sensitive disease (prostate cancer that has spread but responds to ADT). Two studies in The New England Journal of Medicine show that adding a second-generation androgen-receptor blocking drug can further improve survival in such men.
Low-dose aspirin may modestly reduce the risk of death from prostate cancer, though only if taken for an extended period, a study in the Annals of Internal Medicine suggests. Additional research is needed to confirm these findings and to determine whether any potential benefits of long-term aspirin use outweigh the risks.
Making healthier lifestyle choices can help improve your overall health and well-being. And some research suggests that men who follow a healthy diet and exercise regularly have better outcomes after prostate cancer treatment. If your lifestyle before your diagnosis and treatment wasn’t particularly healthy, you can look at this time as an opportunity to get on…
Does drinking alcohol affect the risk of being diagnosed with aggressive, potentially lethal prostate cancer or of developing it after diagnosis? A study in the Journal of Clinical Oncology took a look at these questions. Here’s what the researchers found.
Selenium is an essential trace mineral—that is, it’s needed in small amounts to maintain good health and must be consumed, since the body does not manufacture it. Among its purported benefits: It prevents cancers—notably prostate cancer. But does that claim hold up?
A recent study provides more evidence that androgen deprivation therapy (ADT)—an important treatment for men with or at risk for metastatic prostate cancer— weakens bones. It also identifies the types of fractures most likely to occur. Current guidelines recommend a number of steps that men on ADT should take to boost their bone strength.
Many men, when told they have a Gleason score 6 prostate cancer, worry that their prognosis is bad because the number 6 seems high. But here’s what that score really means—and what doctors are doing to clear up the confusion.
Men who choose active surveillance must live with uncertainty over whether a prostate tumor will turn aggressive. This uncertainty can exact an emotional toll: A study in the Journal of Urology found that 29 percent of men who chose active surveillance developed anxiety about their cancer in the year after diagnosis. Anxiety management strategies, such as…
Despite a lack of scientific support, use of complementary and alternative medicine (CAM) by men with prostate cancer has more than doubled in the United States since the mid-1990s. If you’re one of those men, be sure your doctor knows.
Many men who might benefit from testing for inherited genetic mutations that increase prostate cancer risk aren’t getting screened, according to a 2019 study in JAMA Oncology